Prognostic Implication of a Cuproptosis-Related miRNA Signature in Hepatocellular Carcinoma

Table 1

Clinicopathological parameters of patients with HCC.

Characteristics	No. of patients	Median OS (year)
Age (years)
<60	172 (45.6%)	1.55
≥60	204 (54.1%)	1.73
NA	1 (0.3%)	—
Gender
Female	122 (32.4%)	1.73
Male	255 (67.6%)	1.58
Histologic grade
G1	55 (14.6%)	1.90
G2	180 (47.8%)	1.59
G3	124 (32.9%)	1.58
G4	13 (3.4%)	1.55
NA	5 (1.3%)	—
Pathological stage
I	175 (46.4%)	1.75
II	87 (23.1%)	1.56
III	86 (22.8%)	1.14
IV	5 (1.3%)	0.61
NA	24 (6.4%)	—
T
T1	185 (49.1%)	1.75
T2	95 (25.2%)	1.65
T3	81 (21.5%)	1.12
T4	13 (3.4%)	1.39
NA	3 (0.8%)	—
N
N0	257 (68.2%)	1.63
N1-2	4 (1.1%)	1.79
NA	116 (30.7%)	—
M
M0	272 (72.1%)	1.62
M1	4 (1.1%)	1.07
NA	101 (26.8%)	—

T: tumor; N: node; M: metastasis; OS: overall survival; NA: not available.